Ashok K Prasad Selected Research

1-hydroxyxanthone

11/2002

Xanthones as inhibitors of microsomal lipid peroxidation and TNF-alpha induced ICAM-1 expression on human umbilical vein endothelial cells (HUVECs).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ashok K Prasad Research Topics

Disease

6	Neoplasms (Cancer) 09/2021 - 03/2003
4	Inflammation (Inflammations) 01/2013 - 03/2004
2	Glioma (Gliomas) 09/2021 - 01/2014
2	Colonic Neoplasms (Colon Cancer) 01/2016 - 09/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2011 - 09/2010
2	Necrosis 09/2010 - 11/2002
2	Adenocarcinoma of Lung 05/2009 - 05/2007
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2009 - 05/2007
1	Acute Radiation Syndrome 10/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2016
1	Adenocarcinoma 01/2016
1	Dehydration (Water Stress) 11/2015
1	Asthma (Bronchial Asthma) 01/2013
1	Airway Remodeling 01/2013
1	Metaplasia 01/2013
1	Respiratory Hypersensitivity 01/2013
1	Fibrosis (Cirrhosis) 01/2013
1	Thrombosis (Thrombus) 09/2011
1	Myalgia 07/2011
1	Pulmonary Hypertension 07/2011
1	Rhabdomyolysis 07/2011
1	Chronic Obstructive Pulmonary Disease (COPD) 07/2011
1	Breast Neoplasms (Breast Cancer) 09/2010
1	Myocardial Infarction 09/2010
1	Leukemia 09/2007
1	Aspergillosis 02/2006
1	Carcinoma (Carcinomatosis) 03/2003

Drug/Important Bio-Agent (IBA)

3	Acetates (Acetic Acid Esters)FDA Link 09/2021 - 01/2014
3	Proteins (Proteins, Gene)FDA Link 09/2021 - 03/2011
3	CalreticulinIBA 09/2021 - 03/2011
3	CoumarinsIBA 01/2016 - 03/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2011 - 11/2002
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2011 - 03/2004
3	Cell Adhesion MoleculesIBA 09/2010 - 03/2004
2	coumarinIBA 01/2014 - 05/2009
2	7,8-dihydroxy-4-methylcoumarinIBA 09/2010 - 05/2007
1	ElementsIBA 10/2019
1	AldehydesIBA 11/2015
1	Alkenes (Olefins)IBA 11/2015
1	Histones (Histone)IBA 01/2014
1	AcidsIBA 01/2013
1	8-epi-prostaglandin F2alphaIBA 01/2013
1	CinnamatesIBA 01/2013
1	CytokinesIBA 01/2013
1	OvalbuminIBA 01/2013
1	ferric chlorideIBA 09/2011
1	oxidized low density lipoproteinIBA 07/2011
1	ethyl 4- (4'- heptanoyloxyphenyl)- 6- methyl- 3,4- dihydropyrimidin- 2- one- 5- carboxylateIBA 07/2011
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 07/2011
1	Coenzyme A (CoA)IBA 07/2011
1	Oxidoreductases (Dehydrogenase)IBA 07/2011
1	Protein Kinase CIBA 07/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2011
1	Protein Isoforms (Isoforms)IBA 07/2011
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 07/2011
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 07/2011
1	Biological ProductsIBA 04/2011
1	IonsIBA 09/2010
1	Complex MixturesIBA 09/2010
1	Deferoxamine (Desferal)FDA LinkGeneric 09/2010
1	Chelating AgentsIBA 09/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2010
1	src-Family KinasesIBA 09/2010
1	IronIBA 09/2010
1	NF-kappa B (NF-kB)IBA 05/2009
1	AntioxidantsIBA 05/2009
1	7,8-diacetoxy-4-methylcoumarinIBA 05/2009
1	Phosphotransferases (Kinase)IBA 05/2009
1	7,8-diacetoxy-4-methylthiocoumarinIBA 05/2009
1	Pharmaceutical PreparationsIBA 09/2007
1	Melphalan (Alkeran)FDA LinkGeneric 09/2007
1	DihydropyridinesIBA 02/2006
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 03/2004
1	E-SelectinIBA 03/2004
1	ChromansIBA 03/2003
1	LactonesIBA 03/2003
1	Heterocyclic Compounds (Compounds, Heterocyclic)IBA 03/2003
1	PyrazolesIBA 03/2003
1	ChalconesIBA 03/2003
1	KetonesIBA 03/2003
1	IsoxazolesIBA 03/2003
1	XanthonesIBA 11/2002
1	NADP (NADPH)IBA 11/2002
1	1-hydroxyxanthoneIBA 11/2002

Therapy/Procedure

3	Therapeutics 01/2014 - 03/2011
1	Drug Therapy (Chemotherapy) 03/2011